KATHA GAZDA, FNP-C
Family Nurse Practitioner in ABERDEEN, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KATHA GAZDA, FNP-C reported a CMS MIPS final score of 81.6603/100 — below the 83.1 national average — and filed 2,881 Medicare Part D claims in 2023.
- 81.6603/100
- MIPS score · -1 vs avg
- 3K
- Part D claims, 2023
- 85%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KATHA GAZDA, FNP-C's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
82 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about KATHA GAZDA, FNP-C?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Washington
How Family Nurse Practitioner compares to other specialties among Washington providers
Family Nurse Practitioner share within Washington
Family Nurse Practitioner is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KATHA GAZDA, FNP-C's 2023 MIPS final score plotted against the Family Nurse Practitioner national average
- MIPS Final Score
- 81.6603/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Family Nurse Practitioner) — 81.6603/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Family Nurse Practitioner US NPIs
81.6603/100 MIPS final score — 1.4 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Nurse Practitioner. Quality dim: 74.8677. Cost dim: 87.1074.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KATHA GAZDA, FNP-C appears in the CMS NPPES registry as a Family Nurse Practitioner provider holding FNP-C credentials at 1006 N H ST, ABERDEEN, WA, 98520, with a listed phone of (360) 537-6496. NPI 1144716341 was issued on 07/11/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GAZDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,881 prescription claims written by this provider, covering 191 Medicare beneficiaries and totaling roughly $388K in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 2.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.6603/100 for the 2023 performance year (Quality 74.8677, Cost 87.1074), compared with the national average of 83.1.
Family Nurse Practitioner is a high-volume specialty nationwide, with 209,817 enrolled providers across 56 states and an average of 1,222 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1144716341 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Credentials | FNP-C |
| Gender | Female |
| NPI Issued | 07/11/2018 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KATHA GAZDA, FNP-C's current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to KATHA GAZDA, FNP-C. To verify KATHA GAZDA, FNP-C's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 2,881 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,288
- Total Day Supply
- 183,642
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $318K
- Generic Drug Cost
- $67K
- Opioid Claims
- 79 (2.7% rate)
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 71.5 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 34, 65-74: 81, 75-84: 51, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KATHA GAZDA, FNP-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
151 claims
- Atorvastatin Calcium
Atorvastatin Calcium
145 claims
- Lisinopril
Lisinopril
126 claims
- Omeprazole
Omeprazole
110 claims
- Amlodipine Besylate
Amlodipine Besylate
98 claims
- Gabapentin
Gabapentin
85 claims
- Metoprolol Succinate
Metoprolol Succinate
73 claims
- Losartan Potassium
Losartan Potassium
71 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 151 |
| Atorvastatin Calcium | 145 |
| Lisinopril | 126 |
| Omeprazole | 110 |
| Amlodipine Besylate | 98 |
| Gabapentin | 85 |
| Metoprolol Succinate | 73 |
| Losartan Potassium | 71 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 66 |
| Furosemide | 61 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How KATHA GAZDA, FNP-C fits within the Family Nurse Practitioner landscape nationally.
KATHA GAZDA, FNP-C's 2,881 claims are above the specialty average of 1,222.
Nearby Family Nurse Practitioner Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as GAZDA.
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is KATHA GAZDA, FNP-C's specialty? ▼
How much does KATHA GAZDA, FNP-C prescribe under Medicare Part D? ▼
What is KATHA GAZDA, FNP-C's Medicare quality score? ▼
Where is KATHA GAZDA, FNP-C located? ▼
What is KATHA GAZDA, FNP-C's NPI number? ▼
Does KATHA GAZDA, FNP-C prescribe more brand-name or generic drugs? ▼
Does KATHA GAZDA, FNP-C prescribe opioids? ▼
How many Family Nurse Practitioner providers are there in the US? ▼
What drugs does KATHA GAZDA, FNP-C prescribe most often? ▼
Does KATHA GAZDA, FNP-C accept Medicare? ▼
How can I verify KATHA GAZDA, FNP-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology